AI in Pharma Due Diligence: Leveraging for Licensing and M&A Deals Due diligence (DD) in pharmaceutical licensing and M&A has always been a resource-intensive exercise. Thousands of documents - clinical…
Why Biopharma Companies Are Switching to Internal AI-based Agentic Competitive Intelligence Systems For decades, the biopharmaceutical industry has been reliant on pharma competitive intelligence vendors for secondary research and monitoring…
Agentic AI Competitive Intelligence in Pharma: The Strategic Imperative Competitive intelligence has long served as a foundational pillar for strategic decision-making in the pharmaceutical industry. Yet today, the CI function…
Pharma Out Licensing Challenges and How to Overcome Them Out licensing in pharma and biotech is frequently described as a value-inflection event — a moment when an asset's latent potential…
Essential Strategies for Successful Out-Licensing and Partnering in Pharma and Biotech Industry Dealmaking in the pharmaceutical and biotech industries plays a pivotal role in fostering growth and innovation. Partnering and…
HUMINT in Pharma – Why Superior Primary Research Gives an Edge in Competitive Intelligence In the pharmaceutical industry, information is power. Decisions on R&D, licensing, and product launches can involve…
Key Issues Biotech and Pharma Companies Must Address to Succeed in Out-Licensing Pharma and biotech out-licensing and partnering are essential growth drivers for innovative life sciences companies. Yet, despite repeated…
Leveraging EBITDA Multiples for Accurate Pharma Company Valuations Determining the valuation of pharmaceutical and biotechnology companies is a crucial exercise to inform high-impact decisions including organic investments and prioritization, licensing…
The Pharma CI Threat Matrix: How to Prioritize Threats in the Pharma Competitive Intelligence In today's rapidly evolving pharmaceutical landscape, companies face an overwhelming array of competitive threats. From emerging…
Understanding and Applying Discount Rates for Precise Biopharma Valuations Selecting the appropriate discount rate is essential for pharmaceutical and biotechnology valuations. The discount rate is one of the key drivers…